The Two Speeds of European Healthcare Finland is demonstrating a different approach to modern healthcare—one that prioritizes ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

ON THIS PAGEDigestive Problems'Ozempic Face'Oral Hygiene ChangesHair LossWomen's HealthSee more (11) Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for ...

Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.

Weiner: What is the prevalence of erectile dysfunction among men with diabetes? Jagatic: Men with diabetes have a 3.5 times greater risk for erectile dysfunction (ED) than men without diabetes.

What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).

A new study found that drugs prescribed for erectile dysfunction may help men live longer by improving blood flow and reducing inflammation.

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both conditions.

Tirzepatide showed a 38% reduction in the risk of heart failure outcomes, assessed as a composite endpoint, compared to placebo. Risk of hospitalization for heart failure was reduced by 56%.

The study found participants in the tirzepatide group had a reduced combined risk of cardiovascular death and worsening heart failure events compared to the participants in the placebo group.